| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Upstream Bio, Inc. (UPB) has 11 insiders with recent SEC Form 4 filings, including 5 buys and 0 sells. UPB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 96.0K | $862.6K | - | |
| CEO | 75.0K | $673.9K | - | |
| Other | 75.0K | $673.9K | - | |
| CFO | 30.5K | $274.0K | - | |
| Dir | 17.1K | $153.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 15, 2024 | Ai Upstream LLC | 10% Owner | Buy | 1,175,000 | $17.00 | $19,975,000.00 | New | -50.3% | -5.7% | |
| Oct 15, 2024 | Orbimed Advisors LLC67 | Director, 10% Owner | Buy | 825,000 | $17.00 | $14,025,000.00 | +16.9% | -50.3% | -5.7% | |
| Oct 15, 2024 | Chimovits Erez | Director, 10% Owner | Buy | 825,000 | $17.00 | $14,025,000.00 | +16.9% | -50.3% | -5.7% |